Brain trauma affects millions. Learn about traumatic brain injury (TBI) and post-traumatic stress disorder (PTSD) and how they impact civilians and Veterans.
Cohen Veterans Bioscience is a non-profit 501(c)(3) biomedical research and technology organization dedicated to advancing brain health by fast-tracking precision diagnostics and tailored therapeutics.
Our approach is to build enabling platforms with strategic partners and to adopt a team science approach to fast-track solutions in years, not decades.
PTSD Pre-Clinical Workshop hosted by Cohen Veterans Bioscience
The 2-day workshop brought together 25 scientists who are directly involved in PTSD research or have key experience in this field, with the goal of addressing challenges in PTSD translational science in order to establish a preclinical roadmap to help advance new therapeutics.
Cohen Veterans Bioscience held the PTSD Pre-Clinical Workshop” in Cambridge, MA on February 18-19, 2016. This event was co-chaired by Dr. Kerry Ressler of McLean Hospital and Harvard Medical School, Dr. Cynthia Lemere of Brigham and Women’s Hospital, and Dr. Magali Haas, the CEO of Cohen Veterans Bioscience.
The primary objectives of the workshop were to:
Review the phenomenology of PTSD and existing animal models
Identify factors that contribute to lack of reproducibility and poor translational validity
Assess the criteria of validity necessary to produce translatable preclinical research
Explore available new technologies and how they might be implemented in preclinical PTSD research
Define a roadmap for advancing a PTSD preclinical program in support of translational R&D research
Based on the diverse topics discussed at the PTSD Preclinical Workshop including the heterogeneity of PTSD, the current status of animal models, challenges in developing valid and standardized preclinical model systems and technological advances that may enable innovative PTSD research the group identified clear priorities for the path forward. The overarching goal is to develop standardized animal models of PTSD that are translatable and reproducible in order to de-risk the drug development process. As a first step, it will be necessary to establish a collaborative forum consisting of experts in clinical research, preclinical models, and technology to drive progress along the PTSD Preclinical Roadmap.
Immediate next steps involve convening Working Groups to address specific objectives, including (1) harmonizing rodent behavior models and intermediate phenotypes in humans to facilitate the development of a translatable preclinical model, (2) developing best practice standards for reproducibility of PTSD studies, and (3) exploring innovative nano- and imaging technologies to expand the armamentarium for preclinical research.
Cohen Veterans Bioscience and 22 Jumps Announce Parachuting with Purpose: Recognizing the Epidemic of Veterans Suicide as a Result of Traumatic Brain Injury (TBI) and PTSD
Cohen Veterans Bioscience is a non-profit 501(c)(3) biomedical research and technology organization dedicated to advancing brain health by fast-tracking precision diagnostics and tailored therapeutics.
Manage Cookie Consent
We use cookies to optimize our website.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.